HIV care coverage among HIV-positive adolescent girls and young women in South Africa: Results from the HERStory Study
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

HIV care coverage among HIV-positive adolescent girls and young women in South Africa: Results from the HERStory Study

Filetype[PDF-1.31 MB]


  • English

  • Details:

    • Alternative Title:
      S Afr Med J
    • Description:
      Background.

      Health service coverage cascades measure the proportion of a population in need of a service that experienced a positive health outcome from the service, and enable tracking of progress in achieving universal health coverage and inequities in care coverage.

      Objectives.

      To investigate HIV care coverage among HIV-positive adolescent girls and young women (AGYW) living in six South African districts, compare coverage by age and socioeconomic status (SES), and investigate other associated factors including participation in a combination HIV prevention intervention.

      Methods.

      The HERStory Study was an evaluation of the combination intervention, comprising a representative household survey of AGYW aged 15 – 24 years living in six intervention districts. From September 2017 to November 2018, biological, sociodemographic and behavioural data were collected. HIV-positive status, initiation of antiretroviral therapy (ART) and viral suppression were determined through laboratory tests (enzyme-linked immunosorbent assay for HIV antibodies, antiretroviral (ARV) metabolites and viral load (VL) testing). Viral suppression was defined as a VL <1 000 copies/mL. Knowledge of HIV-positive status was self-reported, and participants testing positive for ARV metabolites were assumed to have known their HIV-positive status. Unconditional HIV care cascades were created, stratified by age and SES. We used Pearson’s χ2 tests corrected for survey-based analysis to describe factors associated with knowledge of HIV status, and being on ART.

      Results.

      Of the 4 399 participants, 568 were HIV-positive (12.4%), of whom 60.8% (95% confidence interval (CI) 57.1 – 64.5) knew their status, 50.6% (95% CI 46.6 – 54.0) were on ART, and 62.1% (95% CI 58.4 – 65.9) were virally suppressed. Most participants (84.9%) were in the lower SES group, and they had better coverage than the higher SES group: 61.9% (95% CI 58.3 – 65.4) knew their status, 52.1% (95% CI 48.4 – 55.9) were on ART, and 64.9% (95% CI 61.3 – 68.4) were virally suppressed, compared with 55.0% (95% CI 42.1 – 68.0), 40.0% (95% CI 29.2 – 50.8), and 46.6% (95% CI 34.5 – 58.7), respectively. Participants aged 15 – 19 years had slightly inferior coverage to the 20 – 24-year-old group: 57.5% knew their status, 46.1% were on ART and 59.5% were virally suppressed, compared with 62.3%, 52.2% and 63.3%.

      Conclusions.

      These findings emphasise the need to close the gaps in HIV care coverage among AGYW, of whom only 61% knew their HIV-positive status and only 62% were virally suppressed. There is pro-poor inequality in HIV care coverage, with those in lower socioeconomic groups more likely to be virally suppressed.

    • Pubmed ID:
      34852889
    • Pubmed Central ID:
      PMC9647633
    • Document Type:
    • Place as Subject:
    • Collection(s):
    • Main Document Checksum:
    • File Type:

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov